TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) has provided an update.
Shanghai MicroPort MedBot (Group) Co., Ltd. has established terms of reference for its Audit Committee to enhance decision-making and oversight processes. The Audit Committee is tasked with supervising internal and external audits, ensuring effective internal controls, and providing accurate financial reporting, thereby strengthening the company’s governance and operational transparency.
The most recent analyst rating on (HK:2252) stock is a Sell with a HK$20.00 price target. To see the full list of analyst forecasts on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H stock, see the HK:2252 Stock Forecast page.
More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
Shanghai MicroPort MedBot (Group) Co., Ltd. is a joint stock company incorporated in China, operating within the medical technology industry. The company focuses on developing innovative medical robotic solutions, enhancing healthcare delivery and patient outcomes.
Average Trading Volume: 5,962,532
Technical Sentiment Signal: Buy
Current Market Cap: HK$22.42B
For detailed information about 2252 stock, go to TipRanks’ Stock Analysis page.